169 related articles for article (PubMed ID: 23490550)
1. Endocannabinoid system and drug addiction: new insights from mutant mice approaches.
Maldonado R; Robledo P; Berrendero F
Curr Opin Neurobiol; 2013 Aug; 23(4):480-6. PubMed ID: 23490550
[TBL] [Abstract][Full Text] [Related]
2. Genetic Manipulation of the Endocannabinoid System.
Zimmer A
Handb Exp Pharmacol; 2015; 231():129-83. PubMed ID: 26408160
[TBL] [Abstract][Full Text] [Related]
3. Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle.
Hutchins-Wiese HL; Li Y; Hannon K; Watkins BA
J Nutr Biochem; 2012 Aug; 23(8):986-93. PubMed ID: 22051448
[TBL] [Abstract][Full Text] [Related]
4. The genetic basis of the endocannabinoid system and drug addiction in humans.
López-Moreno JA; Echeverry-Alzate V; Bühler KM
J Psychopharmacol; 2012 Jan; 26(1):133-43. PubMed ID: 21937688
[TBL] [Abstract][Full Text] [Related]
5. Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system.
El Rawas R; Thiriet N; Nader J; Lardeux V; Jaber M; Solinas M
Brain Res; 2011 May; 1390():80-9. PubMed ID: 21419109
[TBL] [Abstract][Full Text] [Related]
6. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
[TBL] [Abstract][Full Text] [Related]
8. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
[TBL] [Abstract][Full Text] [Related]
9. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
Petrosino S; Di Marzo V
Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid metabolism by cytochrome P450 monooxygenases.
Zelasko S; Arnold WR; Das A
Prostaglandins Other Lipid Mediat; 2015; 116-117():112-23. PubMed ID: 25461979
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.
Rodriguez-Sanchez IP; Guindon J; Ruiz M; Tejero ME; Hubbard G; Martinez-de-Villarreal LE; Barrera-Saldaña HA; Dick EJ; Comuzzie AG; Schlabritz-Loutsevitch NE
Neurotoxicol Teratol; 2016; 58():23-30. PubMed ID: 27327781
[TBL] [Abstract][Full Text] [Related]
12. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
Moreno-Martet M; Mestre L; Loría F; Guaza C; Fernández-Ruiz J; de Lago E
Neurosci Lett; 2012 Feb; 508(2):67-72. PubMed ID: 22206832
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the endocannabinoid system in rat haemochorial placenta.
Fonseca BM; Correia-da-Silva G; Taylor AH; Lam PM; Marczylo TH; Konje JC; Teixeira NA
Reprod Toxicol; 2012 Nov; 34(3):347-56. PubMed ID: 22613199
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
Kerr DM; Downey L; Conboy M; Finn DP; Roche M
Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in drug addiction.
Manzanares J; Cabañero D; Puente N; García-Gutiérrez MS; Grandes P; Maldonado R
Biochem Pharmacol; 2018 Nov; 157():108-121. PubMed ID: 30217570
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the endocannabinoid system in drug addiction.
Maldonado R; Valverde O; Berrendero F
Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
[TBL] [Abstract][Full Text] [Related]
17. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease.
Cappellano G; Uberti F; Caimmi PP; Pietronave S; Mary DA; Dianzani C; Micalizzi E; Melensi M; Boldorini R; Nicosia G; Crosio E; Chiocchetti A; Aina F; Prat M; Dianzani U; Vacca G; Ariatti C; Grossini E
Can J Cardiol; 2013 Apr; 29(4):499-509. PubMed ID: 22926037
[TBL] [Abstract][Full Text] [Related]
18. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.
Chanda PK; Gao Y; Mark L; Btesh J; Strassle BW; Lu P; Piesla MJ; Zhang MY; Bingham B; Uveges A; Kowal D; Garbe D; Kouranova EV; Ring RH; Bates B; Pangalos MN; Kennedy JD; Whiteside GT; Samad TA
Mol Pharmacol; 2010 Dec; 78(6):996-1003. PubMed ID: 20855465
[TBL] [Abstract][Full Text] [Related]
19. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.
Dobrosi N; Tóth BI; Nagy G; Dózsa A; Géczy T; Nagy L; Zouboulis CC; Paus R; Kovács L; Bíró T
FASEB J; 2008 Oct; 22(10):3685-95. PubMed ID: 18596221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
